Effect of Aspirin on Biomarkers of Barrett’s Esophagus After Successful Eradication with Radiofrequency Ablation

By sjmartinez • February 12, 2025

Bresalier RS, Shaheen NJ, Hernandez M, Buttar N, Marcon N, Wani S, Muthusamy R, Falk G, Johnson TT, Yan P, Huo X, Castille TA, Della'Zanna G, Richmond E, Jack Lee J, Brown P, Souza R. Effect of Aspirin on Biomarkers of Barrett's Esophagus After Successful Eradication with Radiofrequency Ablation. Dig Dis Sci. 2025 Feb 11. doi: 10.1007/s10620-025-08908-0. Epub ahead of print. PMID: 39934623.

Tags: Barrett’s esophagus, CDX2, chemoprevention, Digestive Diseases, Eicosanoids, Publications, radiofrequency ablation

Brain-gut crosstalk associated with brain ageing in young and mid-life adults: a multicohort cross-sectional study

Zhao K, Vignolle GA, Labus JS, Mayer EA, Vaughan A, Dy M, Vora P, Hung MW, Vossel K, Gill C, Del Rio D, Stanton C,[...]

Gregory F. Sonnenberg, PhD Appointed Director of the UCLA Center for Research in Inflammatory Bowel Disease

It is with great enthusiasm that we announce that Gregory F. Sonnenberg, PhD, has accepted the appointment as director of the UCLA Center for Research[...]

Radiology considerations for the PREMIUM study: a multicenter randomized controlled trial of abbreviated MRI versus ultrasound for liver cancer screening in cirrhosis

Dunn DP, Dani G, Sharma A, Ioannou GN, Taddei TH, Chang ST, Onyiuke IY, Planeta BM, Huang GD, Weiss NS, Morgan TR, Dominitz JA, Abou-Alfa[...]